LspA inactivation in Mycobacterium tuberculosis results in attenuation without affecting phagosome maturation arrest

Silvana K Rampini1, Petra Selchow1, Christine Keller2

  • 1Institut für Medizinische Mikrobiologie, Universität Zürich, Gloriastrasse 32, CH-8006 Zurich, Switzerland.

Insights

Mycobacterium tuberculosis lacking lipoprotein signal peptidase (LspA) is attenuated because its growth is restricted in early phagosomes, independent of Toll-like receptor 2 signaling or phagosome maturation arrest.

Area of Science:

  • Microbiology
  • Immunology
  • Cell Biology

Background:

  • Mycobacterium tuberculosis (M. tuberculosis) survival relies on evading host macrophage defenses.
  • Phagosome maturation arrest is a key M. tuberculosis virulence mechanism.
  • Lipoprotein signal peptidase (LspA) is crucial for M. tuberculosis virulence.

Purpose of the Study:

  • Investigate the cellular mechanisms behind the attenuation of an M. tuberculosis lspA mutant.
  • Determine the role of Toll-like receptor 2 (TLR2) signaling in M. tuberculosis lspA mutant attenuation.
  • Assess the impact of lspA mutation on phagosome maturation and host immune response.

Main Methods:

  • Studied an lspA mutant of M. tuberculosis in a cellular infection model.
  • Assessed TLR2-dependent immune responses.
  • Measured phagosome maturation using lysosomal-associated membrane protein 1 (LAMP1) co-localization and intraphagosomal pH.

Main Results:

  • The M. tuberculosis lspA mutant's growth control was independent of TLR2 signaling.
  • The lspA mutant arrested phagosome maturation similarly to wild-type M. tuberculosis.
  • Severe attenuation was observed despite normal phagosome maturation arrest.

Conclusions:

  • The M. tuberculosis lspA mutant is severely attenuated in a manner not dependent on TLR2 or typical phagosome maturation arrest.
  • Early phagosome interactions are critical for restricting the growth of the M. tuberculosis lspA mutant.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...